Fig. 1From: The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trialMean change for SDS total (a) and domain (b) scores from baseline to 6-weeks by treatment group. Lurasidone vs. Placebo: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001Back to article page